REQUEST A DEMO
Total
USD $0.00
Search more companies

Salus Pharma Labs Sas (Colombia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Salus Pharma Labs Sas Profile Updated: May 17, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Fabricacion de productos farmaceuticos, sustancias quimicas medicinales y productos botanicos.comercio al por mayor de productos farmaceuticos y medicinales.

Headquarters
Cra 57 # 70 C 29
Bogota D.C.; Bogota D.C; Postal Code: 0223

Contact Details: Purchase the Salus Pharma Labs Sas report to view the information.

Basic Information
Total Employees:
Purchase the Salus Pharma Labs Sas report to view the information.
Outstanding Shares:
Purchase the Salus Pharma Labs Sas report to view the information.
Incorporation Date:
June 30, 2009
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Alternate Fiscal Auditor
Company Performance
Financial values in the chart are available after Salus Pharma Labs Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
25.65%
Total operating revenue
24.23%
Operating profit (EBIT)
55.52%
Total assets
18.65%
Total equity
22.97%
Operating Profit Margin (ROS)
2.86%
Quick Ratio
1.43%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?